In recent years, many promising nanotechnological approaches to biomedical research
have been developed in order to increase implementation of regenerative medicine and …

With the dramatic increase in mortality of cardiovascular diseases (CVDs) caused by
thrombus, this has sparked an interest in seeking more effective thrombolytic drugs or …

Thrombotic disease poses a significant threat to human health as it blocks blood vessels
and leads to severe symptoms. Effective treatment requires targeted therapy and precise …

Thrombosis is a life‐threatening pathological condition in which blood clots form in blood
vessels, obstructing or interfering with blood flow. Thrombolytic agents (TAs) are enzymes …

Smart nano-carriers have attained great significance in the biomedical field due to their
versatile and interesting designs with different functionalities. The initial stages of the …

Nattokinase (NK), a potent thrombolytic enzyme that dissolves blood clots, is highly used in
the treatment of cardiovascular disorders. However, its effective delivery remains demanding …

Peptides are oligomers of amino acids, which have been used in a wide range of
applications, particularly in medical and pharmaceutical sciences. Linear peptides have …

In spinal cord injuries, axonal regeneration decreases with the activation of astrocytes
followed by glial scar formation. Targeting reactive astrocytes has been recently performed …

Nanoparticles containing thrombolytic medicines have been developed for thrombolysis
applications in response to the increasing demand for effective, targeted treatment of …

Peptidomics has rapidly evolved into a multidisciplinary field, integrating high-resolution
mass spectrometry, innovative mesoporous materials and bioinformatics analysis …